Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
Yu‐Yi Chu(National Cheng Kung University), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center)
Cited by 37
Related Papers
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
|Nature Communications|2016|1.1k
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
|Nature Communications|2018|427
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
|Journal of Clinical Investigation|2019|380
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
|Journal of Clinical Investigation|2021|311
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response
|Journal of Clinical Investigation|2015|155